We are live on ! Find out more
AVXL icon

Anavex Life Sciences
AVXL

147 hedge funds and large institutions have $252M invested in Anavex Life Sciences in 2022 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 51 increasing their positions, 32 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

59% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 32

1% more capital invested

Capital invested by funds: $249M → $252M (+$2.15M)

0.9% less ownership

Funds ownership: 32.18% → 31.28% (-0.9%)

2% less funds holding

Funds holding: 150 → 147 (-3)

16% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 19

33% less call options, than puts

Call options by funds: $15.2M | Put options by funds: $22.7M

Holders
147
Holders Change
-3
Holders Change %
-2%
% of All Funds
2.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
51
Reduced
32
Closed
19
Calls
$15.2M
Puts
$22.7M
Net Calls
-$7.49M
Net Calls Change
-$2.17M

Top Buyers

1
Barclays
Barclays
United Kingdom
+$1.89M
2
Bank of America
Bank of America
North Carolina
+$1.46M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$1.26M
4
Rafferty Asset Management
Rafferty Asset Management
New York
+$1.13M
5
CSS
Cubist Systematic Strategies
Connecticut
+$971K

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$6.61M
2
Marshall Wace
Marshall Wace
United Kingdom
-$4.24M
3
Citadel Advisors
Citadel Advisors
Florida
-$2.45M
4
State Street
State Street
Massachusetts
-$1.35M
5
ECM
ExodusPoint Capital Management
New York
-$1.33M
Name Holding Trade Value Shares
Change 		Change in
Stake
QT
76
Quantbot Technologies
New York
$214K +$152K +14,402 +225%
Squarepoint
77
Squarepoint
New York
$207K +$212K +20,068 New
Creative Planning
78
Creative Planning
Kansas
$206K -$169K -16,000 -45%
SFG
79
SNS Financial Group
Minnesota
$206K – – –
Ameriprise
80
Ameriprise
Minnesota
$203K +$24.8K +2,350 +14%
Ensign Peak Advisors
81
Ensign Peak Advisors
Utah
$202K – – –
EFM
82
E Fund Management
China
$194K -$4.53K -429 -2%
Principal Financial Group
83
Principal Financial Group
Iowa
$194K -$4.15K -393 -2%
RCWM
84
Royal Capital Wealth Management
Indiana
$191K – – –
BPA
85
Beacon Pointe Advisors
California
$186K – – –
State Board of Administration of Florida Retirement System
86
State Board of Administration of Florida Retirement System
Florida
$185K – – –
EAM
87
Erste Asset Management
Austria
$176K – – –
TI
88
Trexquant Investment
Connecticut
$173K -$140K -13,271 -44%
GAM
89
Gotham Asset Management
New York
$173K +$24.9K +2,358 +16%
OCG
90
Opus Capital Group
Ohio
$170K – – –
CIBC World Market
91
CIBC World Market
Ontario, Canada
$168K -$1.63K -154 -0.9%
AR
92
Advisory Research
Illinois
$158K +$162K +15,340 New
BCM
93
Brookstone Capital Management
Illinois
$155K -$2.33K -221 -1%
TNB
94
Thomasville National Bank
Georgia
$155K – – –
LSA
95
Leonteq Securities AG
Switzerland
$155K -$3.82K -362 -2%
Los Angeles Capital Management
96
Los Angeles Capital Management
California
$151K +$154K +14,599 New
SG Americas Securities
97
SG Americas Securities
New York
$149K -$201K -19,036 -57%
Royal Bank of Canada
98
Royal Bank of Canada
Ontario, Canada
$149K +$4.83K +458 +3%
ProShare Advisors
99
ProShare Advisors
Maryland
$146K +$5.13K +486 +4%
PNC Financial Services Group
100
PNC Financial Services Group
Pennsylvania
$139K +$63.3K +6,000 +81%
2 3
4
5 6

AVXL Hedge Fund Activity: Q3 2022 in Review

147 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q3 2022, worth a combined $252M — up 0.86% from $249M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of AVXL and 16 opened new positions — a net loss of 3 holders — while 32 trimmed existing stakes and 51 added.

The largest buyer was Barclays, adding an estimated $1.89M. The largest seller was Morgan Stanley, cutting an estimated $6.61M.

  • 147 institutional investors held Anavex Life Sciences (AVXL) as of Q3 2022, down from 150 in Q2 2022.
  • Funds reported $252M of Anavex Life Sciences stock for Q3 2022, up 0.86% quarter-over-quarter.
  • 16 funds opened new Anavex Life Sciences positions in Q3 2022 and 19 closed out, a net change of -3 holders.
  • The largest Anavex Life Sciences buyer in Q3 2022 was Barclays, an estimated $1.89M added.
  • The largest Anavex Life Sciences seller in Q3 2022 was Morgan Stanley, an estimated $6.61M sold.

Based on aggregated 13F filings for Q3 2022.